Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents
Bioorganic & Medicinal Chemistry Letters · 2024
DOI: 10.1016/j.bmcl.2023.129596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2024. Verfasst von Baiyuan Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Calibr, a Division of Scripps Research, La Jolla, CA 92037, USA. Electronic address: byang@scripps.edu. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
To identify new compounds that can effectively inhibit Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), we screened, synthesized, and evaluated a series of novel aryl fluorosulfate derivatives for their in vitro inhibitory activity against Mtb. Compound 21b exhibited an in vitro minimum inhibitory concentration (MIC) of 0.06 µM against Mtb, no cytotoxicity against both HEK293T and HepG2 mammalian cell lines, and had good in vivo mouse plasma exposure and lung concentration with a 20 mg/kg oral dose, which supports advanced development as a new chemical entity for TB treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Calibr, a Division of Scripps Research, La Jolla, CA 92037, USA. Electronic address: byang@scripps.edu.
- Calibr, a Division of Scripps Research, La Jolla, CA 92037, USA.
- Department of Chemistry, Scripps Research, La Jolla, CA 92037, USA.
Förderung
- Bill and Melinda Gates Foundation
Zitieren
APA
Yang, B., Sukheja, P., Qin, B., Li, G., Bare, G. A. L., Cascioferro, A., Love, M. S., Petrassi, H. M., Sharpless, K. B., McNamara, C. W., & Chatterjee, A. K. (2024). Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2023.129596
Vancouver
Yang B, Sukheja P, Qin B, Li G, Bare GAL, Cascioferro A, et al. Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 2024. doi:10.1016/j.bmcl.2023.129596
BibTeX
@article{Yang2024,
author = {Yang, Baiyuan and Sukheja, Paridhi and Qin, Bo and Li, Gencheng and Bare, Grant A L and Cascioferro, Alessandro and Love, Melissa S and Petrassi, H Michael and Sharpless, K Barry and McNamara, Case W and Chatterjee, Arnab K},
title = {Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2024},
doi = {10.1016/j.bmcl.2023.129596}
}
EUVIMED